AbCellera Biologics Inc

2026. szept. 4. 20:08 UTC

Abcellera Biologics Inc shares are lower today amid broader market selling pressure following a strong jobs report, despite earlier gains during the session.

2026. szept. 3. 23:05 UTC

Abcellera Biologics Inc shares are higher in after-market trading, supported by broader market gains amid easing interest rate hike concerns. No specific company news was identified.

2026. szept. 1. 20:08 UTC

Abcellera Biologics Inc shares are lower today amid broader market declines and rising oil prices, which have renewed inflation concerns and interest rate hike expectations.

2026. aug. 31. 23:06 UTC

Abcellera Biologics Inc shares declined in after-market hours, reflecting broader market sentiment influenced by comments on inflation and potential interest rate hikes.

2026. aug. 28. 23:01 UTC

Abcellera Biologics Inc shares are trading lower in after-market hours. No specific company news was identified to explain this movement.

2026. aug. 26. 19:56 UTC

Abcellera Biologics Inc shares are lower today, influenced by declines in the ARK Genomic Revolution ETF and broader genomic sector trends.

2026. aug. 25. 23:06 UTC

Abcellera Biologics Inc. shares declined slightly in after-market trading, despite remaining above their 20-day moving average after recent gains.

2026. aug. 24. 23:36 UTC

Abcellera Biologics Inc. is rising in after-market trading, fueled by a director's $570,000 insider purchase near its 52-week high, indicating insider confidence.

2026. aug. 21. 19:36 UTC

Abcellera Biologics Inc shares are lower today amid broader market pressures. The decline coincides with a drop in U.S. Treasury yields and infrastructure-related assets.

2026. aug. 20. 19:16 UTC

Abcellera shares lower amid broader market pressures, influenced by SPDR ETF.

2026. aug. 19. 23:02 UTC

Abcellera Biologics Inc shares are higher in after-hours trading, reflecting increased investor interest and social media discussions about the stock's potential at $12.20.

2026. aug. 18. 19:56 UTC

Abcellera Biologics Inc shares are lower, influenced by declines in small-cap stocks and rising Treasury yields amid ongoing inflation concerns.

2026. aug. 17. 23:06 UTC

Abcellera Biologics Inc shares are lower in after-market trading, following unusual volatility and a decline in the Russell 2000 Index.

2026. aug. 14. 19:44 UTC

Abcellera Biologics Inc shares are higher today amid increased call option volume and discussions of insider buying, with the stock trading around $10.50.

2026. aug. 13. 19:31 UTC

Abcellera Biologics priced an oversubscribed offering at $9.75 per share, aiming to raise $200 million. Shares are higher since Wednesday's close despite earlier pullback.

2026. aug. 12. 20:02 UTC

Abcellera Biologics has launched a $200 million public offering to support its lead program, while shares are advancing during today's trading session.

2026. aug. 11. 22:51 UTC

Abcellera Biologics announced a $200 million public offering, contributing to a decline in after-market trading amid investor concerns over potential dilution.

2026. aug. 10. 23:06 UTC

Abcellera Biologics reported positive Phase 2 trial results for ABCL635, but shares are lower in after-market hours amid broader market declines.

2026. aug. 8. 00:06 UTC

Abcellera Biologics will release Phase 2 trial results for ABCL635 on August 10, 2026. Shares are trading higher in after-market hours.

2026. aug. 7. 23:21 UTC

Abcellera Biologics will release Phase 2 trial results for ABCL635 on August 10, 2026. Shares are sharply higher in after-market trading amid positive investor sentiment.

2026. aug. 6. 23:06 UTC

Abcellera Biologics Inc. shares are lower in after-market trading, despite earlier reaching a session high and remaining above the 20-day moving average.

2026. aug. 5. 23:02 UTC

Abcellera Biologics shares are lower in after-market hours following disappointing Q2 results, with an EPS of -$0.18 and revenue of $4.1 million.

2026. aug. 3. 19:36 UTC

Abcellera Biologics Inc shares are higher as market sentiment improves following President Trump's cancellation of a military strike on Iran.

2026. júl. 31. 19:33 UTC

Abcellera Biologics Inc is declining during Friday's session, reflecting broader biotech sector weakness amid rising yields and inflation concerns.

2026. júl. 30. 23:41 UTC

Abcellera Biologics shares are lower in after-market trading, reflecting broader market volatility following the Federal Reserve's decision to maintain interest rates.

2026. júl. 29. 23:51 UTC

Abcellera Biologics Inc. shares were roughly flat in after-market hours, with no specific news identified. The stock is down significantly from last month's close.

2026. júl. 28. 19:41 UTC

Abcellera Biologics is rising, driven by gains in the Life Sciences Tools & Services sector and positive trends in the antibody therapeutics market.

2026. júl. 27. 19:46 UTC

Abcellera Biologics Inc shares are higher, reflecting a modest increase since Friday's close. Broader market gains may influence sentiment in life sciences.

2026. júl. 24. 23:46 UTC

Abcellera Biologics Inc shares are higher in after-market hours, showing resilience despite recent challenges in the bond market and declining prices.

2026. júl. 22. 20:06 UTC

Abcellera Biologics Inc shares are lower today, reflecting broader market trends amid uncertainty ahead of the Federal Reserve meeting on July 29.